financetom
Business
financetom
/
Business
/
Tidewater Insider Sold Shares Worth $1,597,992, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Tidewater Insider Sold Shares Worth $1,597,992, According to a Recent SEC Filing
Mar 8, 2024 6:25 AM

09:13 AM EST, 03/08/2024 (MT Newswires) -- Samuel R Rubio, EVP, CFO & CAO, on March 05, 2024, sold 19,641 shares in Tidewater (TDW) for $1,597,992. Following the Form 4 filing with the SEC, Samuel R Rubio has control over a total of 98,036 shares of the company, with 98,036 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/98222/000141588924007216/xslF345X03/form4-03072024_110314.xml

Price: 81, Change: +1.31, Percent Change: +1.64

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Grocery Outlet Holding Names Jason Potter CEO
Grocery Outlet Holding Names Jason Potter CEO
Jan 22, 2025
07:01 AM EST, 01/22/2025 (MT Newswires) -- Grocery Outlet Holding ( GO ) said Wednesday that Jason Potter was named as its new president and chief executive officer, effective Feb. 3. Potter will succeed chairman Eric Lindberg Jr., who held the posts on an interim basis since October, the company said. ...
Abbott forecasts first-quarter profit below estimates
Abbott forecasts first-quarter profit below estimates
Jan 22, 2025
(Reuters) -Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street estimates, along with weak fourth-quarter sales in segments other than medical devices, sending its shares down 1% in premarket trading. The company expects a first-quarter adjusted profit of $1.05 to $1.09 per share, missing analysts' average estimate of $1.11. Revenue for the fourth quarter rose 7.2% to $10.97 billion,...
Abbott forecasts in line annual profit on medical device sales
Abbott forecasts in line annual profit on medical device sales
Jan 22, 2025
Jan 22 (Reuters) - Abbott Laboratories ( ABT ) on Wednesday forecast annual profit in line with Wall Street estimates, as it expects elevated medtech-related procedures to boost demand for its devices, including glucose-monitoring products. Sales of continuous glucose monitors such as Abbott's FreeStyle Libre and rivals from DexCom ( DXCM ) have been lifted by increasing diabetes care awareness,...
Insurance giant Travelers beats profit estimates on stronger underwriting
Insurance giant Travelers beats profit estimates on stronger underwriting
Jan 22, 2025
(Reuters) -Property and casualty insurer Travelers beat estimates for fourth-quarter profit on Wednesday, as strength in its underwriting business cushioned a blow from elevated catastrophe losses. Shares of the company rose nearly 3% to $246.01 before the bell. Individuals and companies are increasing their spending on insurance in response to rising economic uncertainty and risks, enabling insurers to attract and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved